Recent News About Johnson & Johnson View More
- Hot Topics
HARRISBURG – According to the Supreme Court of Pennsylvania, it will not hear an appeal of the first Risperdal case to be decided in the hands of a Philadelphia jury and its $2.5 million verdict for the plaintiff will stand.
- Federal Court
TRENTON, N.J. – Eight days of scientific expert witness testimony in a New Jersey federal court, centered on whether Johnson & Johnson’s talc-containing baby powder causes women to develop both ovarian cancer and mesothelioma, will conclude Wednesday and ultimately determine if 12,000 lawsuits on the subject move forward.
- Federal Court
Facing 12,000 lawsuits, J&J has expert testify that there is no link between talc and ovarian cancer
TRENTON, N.J. – The fate of about 12,000 lawsuits claiming Johnson & Johnson’s talc-containing baby powder causes women to develop both ovarian cancer and mesothelioma, will be decided after eight days of expert witness testimony in a New Jersey federal court.
- State Court
HARRISBURG – The Superior Court of Pennsylvania has reinstated a Risperdal lawsuit which was thrown out after 11 days of trial proceedings in a Philadelphia court in December 2016 and said its original granting of nonsuit was improper.
Johnson & Johnson exec engaged in settlement talks over fateful April 2018 Southwest Airlines flight
PHILADELPHIA – Settlement proceedings are ongoing in an action filed by a man on board the infamous Southwest Airlines flight from April 2018 on which one passenger was partially sucked out of the plane and later died.
PHILADELPHIA – Just weeks after a Philadelphia jury reached a $120 million verdict against Johnson & Johnson and its subsidiary, Ethicon, Inc. and in favor of a plaintiff who claimed she suffered at the hands of a defectively-designed pelvic mesh device, another jury in a similar action has handed down a verdict of $80 million.
PHILADELPHIA – Another lawsuit from an out-of-state plaintiff joins others in targeting Johnson & Johnson’s Invokana medication for Type 2 diabetes, alleging the company failed to warn him that the drug put him at increased risk for the gangrene he sustained from taking it.